In a 47‑year‑old woman with a DHEA‑sulfate level of 199 ng/dL and a morning cortisol level of 7.6 µg/dL, what is the clinical significance and what evaluation and management steps are recommended?

Clinical Significance and Management of DHEA-S 199 ng/dL and Morning Cortisol 7.6 µg/dL

These laboratory values are concerning for possible primary adrenal insufficiency (PAI) and require immediate confirmatory testing with an ACTH stimulation test, as the morning cortisol of 7.6 µg/dL falls in the indeterminate range and the DHEA-S of 199 ng/dL is likely low for a 47-year-old woman.

Interpretation of Laboratory Values

Morning Cortisol Assessment

The morning cortisol of 7.6 µg/dL (approximately 210 nmol/L) falls into a diagnostic gray zone. According to the Endocrine Society guidelines, PAI is highly likely when morning cortisol is <5 µg/dL (140 nmol/L) combined with elevated ACTH 1. Your patient's value sits above this threshold but below the reassuring level of ≥10 µg/dL, where adrenal insufficiency becomes extremely unlikely 2.

DHEA-S Interpretation

The DHEA-S level of 199 ng/dL requires age- and sex-specific interpretation. DHEA-S levels well below the lower limit of normal for age and sex are a useful initial sign of PAI that should not be overlooked 1. For a 47-year-old woman, this value may represent the lower end of normal or be frankly low, depending on the laboratory's reference range.

Critically, while low DHEA-S cannot diagnose PAI in isolation, a normal age- and sex-adjusted DHEA-S level practically rules out the diagnosis of adrenal insufficiency 3, 4. The combination of borderline-low cortisol with potentially low DHEA-S increases suspicion for adrenal dysfunction.

Required Diagnostic Workup

Immediate Next Steps

1. Measure plasma ACTH level - This is essential to differentiate primary from secondary adrenal insufficiency. In PAI, ACTH should be elevated >2-fold above the upper limit of normal 1.

2. Perform ACTH stimulation test (cosyntropin test) - This is the diagnostic gold standard for PAI 1:

   • Administer 250 µg cosyntropin IV or IM
   • Measure cortisol at baseline, 30, and 60 minutes
   • The test can be performed at any time of day without time constraints 1
   • Do not delay this test - it should be performed promptly unless basal results are absolutely unequivocal

3. Additional baseline measurements (if PAI suspected):

   • Plasma aldosterone
   • Plasma renin activity
   • Serum electrolytes (sodium, potassium)
   • Age- and sex-adjusted DHEA-S reference range confirmation

Diagnostic Thresholds

Recent research demonstrates that only 1.3% of patients with baseline cortisol between 5-9.9 µg/dL had adrenal insufficiency if DHEA-S was ≥60 µg/dL 2. Your patient's DHEA-S of 199 ng/dL (if this equals approximately 199 µg/dL) would be reassuring, but if the units are truly ng/dL, this represents severe deficiency requiring urgent evaluation.

Clinical Assessment Priorities

Symptoms to Evaluate

Specifically assess for:

• Fatigue and low energy levels (most common)
• Postural hypotension (measure blood pressure supine and standing)
• Salt craving
• Weight loss
• Hyperpigmentation (suggests primary adrenal insufficiency with elevated ACTH)
• Nausea, vomiting, abdominal pain
• History of adrenal crises (life-threatening)

Risk Stratification

The combination of cortisol 7.6 µg/dL with low DHEA-S places this patient at moderate-to-high risk for adrenal insufficiency. Patients with both baseline cortisol <5 µg/dL and DHEA-S <25 µg/dL have a 72.2% probability of confirmed AI 2. While your patient's cortisol is slightly higher, the potentially low DHEA-S warrants urgent evaluation.

Management Algorithm

If PAI is Confirmed:

1. Initiate glucocorticoid replacement immediately 1:

   • Hydrocortisone 15-25 mg daily in 2-3 divided doses
   • Highest dose in the morning upon awakening
   • Second dose in early afternoon (2-dose regimen) or split between lunch and afternoon (3-dose regimen)

2. Add mineralocorticoid replacement 1:

   • Fludrocortisone 50-100 µg daily (starting dose)
   • Advise against salt restriction
   • Monitor with clinical assessment (salt craving, postural BP, edema) and electrolytes

3. Consider DHEA replacement trial 1:

   • Specifically indicated for women with PAI who have low libido, depressive symptoms, and/or low energy despite optimized glucocorticoid and mineralocorticoid replacement
   • Dose: 25-50 mg orally once daily in the morning
   • Trial period: 6 months
   • Discontinue if no sustained benefit after 6 months
   • Monitor morning DHEA-S levels (aim for mid-normal range)

4. Patient education on stress dosing - Critical for preventing adrenal crisis during illness, surgery, or major stress 1.

5. Endocrinology referral - All PAI patients should be seen by an endocrinologist at least annually 1.

Critical Pitfalls to Avoid

• Do not rely on DHEA-S alone for diagnosis - It must be confirmed with ACTH stimulation testing 1, 3
• Do not delay testing if clinical suspicion is high - Adrenal crisis is life-threatening
• Verify laboratory units - Confirm whether DHEA-S is reported in ng/dL or µg/dL, as this dramatically changes interpretation
• Do not use dexamethasone for chronic replacement - Risk of Cushingoid side effects due to dosing difficulties 1
• Remember age-related decline - DHEA-S naturally declines with age, particularly after age 30, so age-specific reference ranges are essential 1

The combination of these laboratory values in a 47-year-old woman mandates prompt, systematic evaluation to prevent potentially life-threatening adrenal crisis while avoiding unnecessary treatment if adrenal function is ultimately normal.